Enzyme vs NEAR Protocol — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while NEAR Protocol trades at Rp28,485 (market cap Rp37,25T, Rp1,87T 24h volume). The key difference: NEAR Protocol is far larger — about 277715.6× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 1,3B NEAR for NEAR Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and NEAR Protocol for 51 Days on average.
| MLN | NEAR | |
|---|---|---|
Market Cap | Rp134,13M | Rp37,25T |
Volume (24h) | Rp104,56M | Rp1,87T |
Circulating Supply | 3,3M MLN | 1,3B NEAR |
Typical Hold Time | 29 Days | 51 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
NEAR Protocol is trading at Rp 28,341 with a market cap of Rp 36.87T, showing bearish technical signals from moving averages while oscillators are neutral. The current price sits between support at Rp 28,561 and resistance at Rp 29,779, indicating consolidation. Recent news highlights NEAR's potential appeal in a lower interest rate environment as a crypto alternative.
Overall outlook is cautious due to bearish technicals but with neutral momentum. Key opportunities include ecosystem growth and rate sensitivity, while major risks involve high volatility and regulatory uncertainty in crypto markets.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →NEAR is a sharded, developer-friendly, proof-of-stake public blockchain, built by a world-class team that has built some of the world's only sharded databases at scale. The network runs on a Proof-of-Stake (PoS) convention mechanism called Nightshade, which aims to offer scalability and stable costs. nn
Read more on NEAR →